Abstract
Recent years have seen a number of attempts to define the field of regenerative medicine (RM) published in the scientific literature. Key issues addressed include which technologies belong under the umbrella of RM, where the proper origins of the field lie, and what the prospects are for its future. I argue that these competing visions for the field are qualitatively different from the initial technological expectations deployed when RM began to emerge in the 1990s and represent a qualitatively different ‘stage’ of the field's development. A significant characteristic of this stage is that proponents of RM must not only continue to present hope for the field, but also account for prior sets of expectations that have been, at least partly, unfulfilled. Drawing on work from the sociology of expectations and STS (science and technology studies)-informed studies on scientific disciplinarity, these recent definitions of RM are analysed in terms of the promissory work they do and the means they employ to do it. Particular attention is drawn to the deployment of historiographic ‘origin stories’ to support competing accounts of RM. These ‘possible pasts’ act as a discursive means of colonising the past in order to reconcile prior unfulfilled promises with current visions of the field.
Similar content being viewed by others
Notes
The REMEDiE project's definition of RM along with the major findings from the project can be found in the project's final report accessible at www.cs.york.ac.uk/socdep/. Access is free but requires registration.
The cloning of Dolly is relevant to RM because applied to humans this technology offered a potential means to create embryos with a genetic match to any individual patient as a source stem cells for future RM applications. Such patient-specific cells should theoretically avoid the danger of immune rejection, or the need for immuno-suppressive drugs associated with conventional transplants of organs and cells.
References
Abir-Am, P. (1985) Themes, genres and orders of legitimation in the consolidation of new scientific disciplines: Deconstructing the historiography of molecular biology. History of Science 23 (59): 73–117.
Bajada, S., Mazakova, I., Richardson, J.B. and Ashammakhi, N. (2008) Updates on stem cells and their applications in regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine 2 (4): 169–183.
Brown, N. (2003) Hope against hype: Accountability in biopasts, presents and futures. Science Studies 16 (2): 3–21.
Brown, N., Kraft, A. and Martin, P. (2006) The promissory pasts of blood stem cells. BioSocieties 1 (3): 329–348.
Brown, N. and Michael, M. (2003) A sociology of expectations: Retrospecting prospects and prospecting retrospects. Technology Analysis & Strategic Management 15 (1): 3–18.
Calvert, J. and Fujimura, J. (2011) Calculating life? Duelling discourses in interdisciplinary systems biology. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 42 (2): 155–163.
Cooper, M. (2006) Resuscitations: Stem cells and the crisis of old age. Body & Society 12 (1): 1–23.
Daar, A.S. and Greenwood, H.L. (2007) A proposed definition of regenerative medicine. Tissue Engineering 1 (3): 179–184.
Daley, G.Q. and Scadden, D.T. (2008) Prospects for stem cell-based therapy. Cell 132 (4): 544–548.
Franklin, S. and McNeil, M. (1993) Editorial: Procreation stories. Science as Culture 3 (4): 477–482.
Gardner, R.L. (2007) Stem cells and regenerative medicine: Principles, prospects and problems. Comptes Rendus Biologies 330 (6–7): 465–473.
Geesink, I., Prainsack, B. and Franklin, S. (2008) Stem cell stories 1998–2008. Science as Culture 17 (1): 1–11.
Hall, S.S. (2003) Merchants of Immortality: Chasing the Dream of Human Life Extension. New York: Houghton Mifflin Company.
Hedgecoe, A. and Martin, P. (2003) The drugs don’t work: Expectations and the social shaping of pharmacogenetics. Social Studies of Science 33 (3): 327–364.
Hedgecoe, A.M. (2003) Terminology and the construction of scientific disciplines: The case of pharmacogenomics. Science, Technology and Human Values 28 (4): 513–537.
Kemp, P. (2006) History of regenerative medicine: Looking backwards to move forwards. Regenerative Medicine 1 (5): 653–669.
Kitzinger, J. (2008) Questioning hype, rescuing hope? The Hwang stem cell scandal and the reassertion of hopeful horizons. Science as Culture 17 (4): 417–434.
Kitzinger, J. and Williams, C. (2005) Forecasting science futures: Legitimising hope and calming fears in the embryo stem cell debate. Social Science & Medicine 61 (3): 731–740.
Knorr Cetina, K. (1999) Epistemic Cultures: How the Sciences Make Knowledge. Cambridge, MA: Harvard University Press.
Kuhn, T.S. (1996) The Structure of Scientific Revolutions, 3rd edn. Chicago, IL: Chicago University Press.
Van Lente, H. and Rip, A. (1998) The rise of membrane technology: From rhetorics to social reality. Social Studies of Science 28 (2): 221–254.
Lysaght, M., Jaklenec, A. and Deweerd, E. (2008) Great expectations: Private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Engineering: Part A 14 (2): 305–319.
Mason, C. (2007a) Regenerative medicine 2.0. Regenerative Medicine 2 (1): 11–18.
Mason, C. (2007b) Regenerative medicine – The industry comes of age, http://www.organogenesis.com/news/media_coverage/articles/pdf/regenerative_medicine.pdf, accessed 27 October 2010.
Mason, C. and Dunnill, P. (2008) A brief definition of regenerative medicine. Regenerative Medicine 3 (1): 1–5.
Mason, C. and Manzotti, E. (2009) Regen: The industry responsible for cell-based therapies. Regenerative Medicine 4 (6): 783–785.
Van Merkerk, R. and Robinson, D. (2006) Characterizing the emergence of a technological field: Expectations, agendas and networks in lab-on-a-chip technologies. Technology Analysis & Strategic Management 18 (3–4): 411–428.
Michael, M., Wainwright, S.P. and Williams, C. (2005) Temporality and prudence: On stem cells as ‘phronesic things’. Configurations 13 (3): 373–394.
Moreira, T. and Palladino, P. (2005) Between truth and hope: On Parkinson's disease, neurotransplantation and the production of the ‘self’. History of the Human Sciences 18 (3): 55–82.
National Institute of Health/Department of Health and Human Services. (2006) Regenerative medicine, http://stemcells.nih.gov/info/scireport/2006report.htm, accessed 22 June 2009.
Nerem, R.M. (2010) Regenerative medicine: The emergence of an industry. Journal of the Royal Society Interface 7 (53): S771–S775.
Nerlich, B. and Dingwall, R. (2003) Deciphering the human genome: The semantic and ideological foundations of genetic and genomic discourse. In: R. Dirven, R. Frank and M. Putz (eds.) Cognitive Models in Language and Thought: Ideologies, Metaphors and Meaning. Berlin: Moutoun de Gruyter, pp. 396–428.
Polykandriotis, E., Popescu, L.M. and Horch, R.E. (2010) Regenerative medicine: Then and now – An update of recent history into future possibilities. Journal of Cellular and Molecular Medicine 14 (10): 2350–2358.
Powell, A., O'Malley, M.A., Muller-Wille, S., Calvert, J. and Dupré, J. (2007) Disciplinary baptisms: A comparison of the naming stories of genetics, molecular biology, genomics and systems biology. History and Philosophy of the Life Sciences 29 (1): 5–32.
Prainsack, B., Geesink, I. and Franklin, S. (2008) Stem cell technologies 1998–2008: Controversies and silences. Science as Culture 17 (4): 351–362.
Sheyn, D., Mizrahi, O., Benjamin, S., Gazit, Z., Pelled, G. and Gazit, D. (2010) Genetically modified cells in regenerative medicine and tissue engineering. Advanced Drug Delivery Reviews 62 (7–8): 683–698.
Singh, P. and Williams, D.J. (2008) Cell therapies: Realizing the potential of this new dimension to medical therapeutics. Journal of Tissue Engineering and Regenerative Medicine 2 (6): 307–319.
Tutton, R. (2011) Promising pessimism: Reading the futures to be avoided in biotech. Social Studies of Science 41 (3): 411–429.
Williams, D.J. and Sebastine, I.M. (2005) Tissue engineering and regenerative medicine: Manufacturing challenges. IEE Proceedings Nanobiotechnology 152 (6): 207–210.
Yu, J. and Thompson, J. (2006) Embryonic stem cells. In: National Institute of Health/Department of Health and Human Services (ed.) Regenerative Medicine, NIH, pp. 1–12, http://stemcells.nih.gov/info/scireport/2006report.htm.
Acknowledgements
I thank the four anonymous referees for their constructive and helpful comments during the review process. Thanks are also due to Andrew Webster and attendees of a SATSU ‘brown bag’ seminar who commented on earlier drafts of this article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, M. Promissory futures and possible pasts: The dynamics of contemporary expectations in regenerative medicine. BioSocieties 7, 3–22 (2012). https://doi.org/10.1057/biosoc.2011.24
Published:
Issue Date:
DOI: https://doi.org/10.1057/biosoc.2011.24